ALNY in the 13F filings
Alnylam Pharmaceuticals Inc · CUSIP 02043Q107
- Quarter end
- 30 Jun 2025
- the date the book describes
- Filed
- 14 Aug 2025
- latest of these filings; the earliest 6 Aug 2025
- Managers listing it
- 22
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q1 2025 and Q2 2025; 14 listed it in both
- Shares listed
- 56,189,777
- combined, among listed positions
- Reported value
- $18.3bn
- combined, at the quarter end
Among the 95 comparable managers: 13 buyers (opened or added shares) and 10 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing ALNY in Q2 2025
22 of 22 holders
Largest increases and reductions, by shares
Increases
- Holocene Advisors LPnew position · 596,816 shares now+596,816
- Fidelity (FMR LLC)existing position · 15,806,521 shares now+496,661
- Woodline Partners LPexisting position · 623,115 shares now+466,651
- Two Sigma Investments LPexisting position · 343,305 shares now+145,890
- Capital World Investorsexisting position · 16,805,007 shares now+55,384
Reductions
- AQR Capital Management LLCexisting position · 188,249 shares now-640,095
- Baillie Gifford & Coexisting position · 3,031,891 shares now-625,716
- Wellington Management Group LLPexisting position · 2,075,752 shares now-535,234
- T. Rowe Price Associates Incexisting position · 3,145,006 shares now-360,162
- Dodge & Coxexisting position · 3,197,096 shares now-154,666
New positions and exits
New (2)
- Holocene Advisors LP$195m
- Winton Group Ltd$1.2m
Exited (1)
- Soros Fund Management LLCwas $16m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 4 | $407m | n.a. | n.a. |
| Q3 2013 | 6 | $1.2bn | n.a. | n.a. |
| Q4 2013 | 7 | $1.5bn | n.a. | n.a. |
| Q1 2014 | 8 | $1.6bn | n.a. | n.a. |
| Q2 2014 | 6 | $1.7bn | n.a. | n.a. |
| Q3 2014 | 7 | $2.1bn | n.a. | n.a. |
| Q4 2014 | 6 | $2.2bn | n.a. | n.a. |
| Q1 2015 | 8 | $2.9bn | n.a. | n.a. |
| Q2 2015 | 6 | $3.3bn | n.a. | n.a. |
| Q3 2015 | 5 | $2.1bn | n.a. | n.a. |
| Q4 2015 | 6 | $2.7bn | n.a. | n.a. |
| Q1 2016 | 8 | $2.0bn | n.a. | n.a. |
| Q2 2016 | 7 | $2.0bn | n.a. | n.a. |
| Q3 2016 | 8 | $2.6bn | n.a. | n.a. |
| Q4 2016 | 8 | $1.6bn | n.a. | n.a. |
| Q1 2017 | 9 | $2.2bn | n.a. | n.a. |
| Q2 2017 | 14 | $3.8bn | n.a. | n.a. |
| Q3 2017 | 15 | $5.7bn | n.a. | n.a. |
| Q4 2017 | 14 | $6.3bn | n.a. | n.a. |
| Q1 2018 | 15 | $5.7bn | n.a. | n.a. |
| Q2 2018 | 15 | $4.4bn | n.a. | n.a. |
| Q3 2018 | 14 | $3.9bn | n.a. | n.a. |
| Q4 2018 | 10 | $3.3bn | n.a. | n.a. |
| Q1 2019 | 11 | $4.6bn | n.a. | n.a. |
| Q2 2019 | 16 | $3.8bn | n.a. | n.a. |
| Q3 2019 | 11 | $4.4bn | n.a. | n.a. |
| Q4 2019 | 13 | $6.2bn | n.a. | n.a. |
| Q1 2020 | 12 | $5.7bn | n.a. | n.a. |
| Q2 2020 | 15 | $7.7bn | n.a. | n.a. |
| Q3 2020 | 13 | $7.6bn | n.a. | n.a. |
| Q4 2020 | 13 | $6.5bn | n.a. | n.a. |
| Q1 2021 | 14 | $7.2bn | n.a. | n.a. |
| Q2 2021 | 13 | $8.8bn | n.a. | n.a. |
| Q3 2021 | 14 | $9.7bn | n.a. | n.a. |
| Q4 2021 | 12 | $8.8bn | n.a. | n.a. |
| Q1 2022 | 12 | $8.9bn | n.a. | n.a. |
| Q2 2022 | 13 | $8.1bn | n.a. | n.a. |
| Q3 2022 | 17 | $10.8bn | n.a. | n.a. |
| Q4 2022 | 16 | $13.7bn | n.a. | n.a. |
| Q1 2023 | 19 | $11.5bn | n.a. | n.a. |
| Q2 2023 | 16 | $10.6bn | n.a. | n.a. |
| Q3 2023 | 17 | $9.7bn | n.a. | n.a. |
| Q4 2023 | 15 | $10.0bn | 5 | 9 |
| Q1 2024 | 15 | $7.3bn | 10 | 6 |
| Q2 2024 | 19 | $12.5bn | 12 | 8 |
| Q3 2024 | 18 | $15.1bn | 7 | 11 |
| Q4 2024 | 15 | $12.8bn | 8 | 7 |
| Q1 2025 | 18 | $14.9bn | 11 | 7 |
| Q2 2025 | 22 | $18.3bn | 13 | 10 |
| Q3 2025 | 33 | $26.6bn | 25 | 8 |
| Q4 2025 | 24 | $23.4bn | 15 | 28 |
| Q1 2026 | 22 | $17.9bn | 16 | 18 |
| Q2 2026 | 21 | $15.9bn | 17 | 18 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ALNY and LLY →ALNY and JNJ →ALNY and VRTX →Choose a stock to compare with ALNY →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ALNY, latest filings →Back to the 13F Explorer →